Leslie Itsara, PhD, is the Program Director at MalarVx.  She received her PhD in Molecular and Cellular Biology from the University of Washington, Seattle, in 2013 and a BS in Molecular and Cellular Biology from Vanderbilt University in 2007.  She is responsible for overseeing the in vitro sporozoite and vaccine development program for the company.